Stroke prevention Deep vein thrombosis Pulmonary embolism
Manufactured under WHO-GMP compliant processes at our US FDA approved facility in Baddi, Himachal Pradesh.
Rigorous quality control at every stage ensures reliable purity and potency across every batch produced.
Trusted by pharmaceutical partners and distributors across 90+ countries worldwide.
nhibits platelet activation and fibrin clot formation via direct, selective and reversible inhibition of factor Xa (FXa) in both the intrinsic and extrinsic coagulation pathways. FXa, as part of the prothrombinase complex consisting also of factor Va, calcium ions, factor II and phospholipid, catalyzes the conversion of prothrombin to thrombin.